Introduction {#s1}
============

The habenula is an epithalamic structure divided into medial (MHb) and lateral (LHb) subregions that receives diverse input from the basal ganglia, frontal cortex, basal forebrain, hypothalamus and other regions involved in processing both sensory information and internal state ([@bib15]; [@bib58]). Two main targets of the LHb output are major monoaminergic structures in the brain, the ventral tegmental area (VTA) and raphe nuclei (dorsal (DRN) and medial (MRN)), whereas the MHb targets the interpeduncular nucleus ([@bib16]). Due to its dual effects on dopamine and serotonin-producing neurons, LHb has been proposed to contribute to the neurobiological underpinnings of depression and addiction ([@bib27]; [@bib28]; [@bib29]; [@bib31]). Furthermore, the LHb has been implicated in a wide range of functions and behaviors including reward prediction error, aversion, cognition, and adaptive decision making ([@bib17]; [@bib30]; [@bib32]; [@bib36]; [@bib48]; [@bib54]).

The effects of LHb on each downstream structure and its contribution to different behaviors are likely carried out by distinct populations of neurons. In addition, the LHb may, at the macroscopic level, consist of distinct sub-domains with differential contributions to limbic and motor functions ([@bib59]). Further, many studies suggest that habenular neurons show differences in gene expression across hemispheres ([@bib8]; [@bib35]), projection targets ([@bib37]), and anatomical location ([@bib13]). Nevertheless, the systematic relationship between molecular profiles, projections patterns, and anatomical organization of neurons in the LHb is unknown.

Here, we provide a comprehensive description of the neuronal subtypes in the LHb based on single-cell transcriptional profiling, multiplexed fluorescent in situ hybridization (FISH), and cell-type-specific monosynaptic retrograde tracing. Furthermore, as the MHb was included in our dissections, we also provide a molecular description of this nucleus. We find that the MHb has five, and LHb has four, transcriptionally defined neuronal subtypes. Interestingly, the HbX subtype, which lies at the border between the MHb and LHb, is more transcriptionally similar to other LHb subtypes than MHb subtypes. We find that the four LHb neuronal subtypes are distinct and monosynaptic retrograde tracing revealed that they differentially target the dopaminergic and GABAergic neurons of the VTA, as well as the dorsal raphe nucleus. Furthermore, we find the LHb is organized into subregions defined by these transcriptionally discriminable neuronal subtypes. Together we identify previously unknown neuronal heterogeneity in the habenula and reveal that different neuronal classes are biased in their projection targets.

Results {#s2}
=======

Cell type composition of the habenula by transcriptomic profiling {#s2-1}
-----------------------------------------------------------------

To examine cellular heterogeneity in the habenula, we performed high-throughput single-cell transcriptional profiling ('InDrop') ([@bib22]). Cell suspensions from the habenula were generated from acute, microdissected brain slices from adult mice ([Figure 1A](#fig1){ref-type="fig"}), producing 25,289 single-cell transcriptomes (SCTs). Excluding SCTs with \<200 genes,\<500 UMIs, or \>10% mitochondrial genes resulted in 7,506 SCTs that were further analyzed. This subset had median counts of 2593 UMIs (min = 501, max = 17787, IQR = 3986) and 349 genes (min = 302, max = 5276, IQR = 1733) per cell ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). Subsequent analysis of gene expression patterns by principal components (PC) analysis and shared-nearest-neighbors ([@bib42]) resulted in 12 cellular clusters ([Figure 1B](#fig1){ref-type="fig"}, see Materials and methods for details on sequential clustering). Major cell classes (i.e. neurons, astrocytes, microglia, etc...) within these clusters were identified by expression of cell-type-specific gene combinations that were extensive cross-referenced with published datasets ([@bib43]; [@bib60]) ([Figure 1B--C](#fig1){ref-type="fig"}). Our data confirmed recent work on non-neuronal cell-types in habenula describing high levels of *Tnf* in microphages and microglia ([@bib50]) and high levels of Kir4.1 (*Kcnj10*) in astrocytes ([@bib9]) ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). In contrast to other species ([@bib35]), no major transcriptional differences were observed ([Figure 1---figure supplement 1A--B](#fig1s1){ref-type="fig"}) across left and right hemispheres; therefore, cells from both hemispheres were pooled for analysis. The majority of the cells in the dataset were neurons (53%) and we focused our analysis on these clusters for the remainder of the study.

![High-throughput single-cell transcriptomic profiling of the habenula.\
(**A**) Schematic for scRNA-seq using the inDrop platform. Tissue containing the habenula was microdissected from acute coronal brain slices prepared from adult mice (1). Tissue chunks were digested in a cocktail of proteases and followed by trituration and filtration to obtain a cell suspension (2). Single cells were encapsulated using a droplet-based microfluidic device (3) for cell barcoding and mRNA capture (4). RNA sequencing (5) and bioinformatics analysis followed (6). (**B**) t-SNE plot of the processed dataset containing 7,506 cells from six animals. Cells are color-coded according to the cluster labels shown in (**C**). (**C**) Left: Dendrogram with cell class labels corresponding to clusters shown in (**B**). Right: Dot plot displaying expression of example enriched genes used to identify each major cell class. The color of each dot (blue to red) indicates the relative log-scaled expression of each gene, whereas the dot size indicates the fraction of cells expressing the gene.](elife-51271-fig1){#fig1}

Neurons (*n* = 3,930 cells), identified by expression of genes required for chemical synaptic transmission such as *Snap25*, *Syp,* and *Syt4,* clustered into two main classes ([Figure 1B--C](#fig1){ref-type="fig"}). We examined if these two neuronal clusters could be spatially distinguished using digital in situ hybridization (ISH) analysis (Allen Brain Atlas, \[[@bib26])\] of differentially expressed genes ([@bib11]). The larger cluster of neurons (n = 3,370 cells) expressed *Tac2* and corresponds to the MHb ([Figure 2](#fig2){ref-type="fig"}), whereas the smaller cluster (n = 560 cells) expressed *Gap43* and corresponds to the LHb ([Figure 3](#fig3){ref-type="fig"}).

![MHb neuron subtypes can be distinguished transcriptionally.\
(**A**) Location of MHb and ISH of *Tac2* expression from the Allen Institute Database. *Tac2* expression is restricted to cells in the MHb in this region. (**B**) *Tac2* serves as an excellent marker for MHb neurons in the dataset of SCTs (Scale on right shows normalized (log) gene expression.) (**C**) Left: Illustration showing patterns of gene expression observed for DEGs using the Allen Institute Database. Right: Sample ISH images from the Allen Institute Database showing selected differentially expressed genes for distinct transcriptionally defined neuronal subtypes in MHb. (**D**) Left: Dendrogram with MHb subtype labels corresponding to clusters shown in ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). Right: Heatmap showing the relative expression (mean z- scored) of selected genes that are enriched in each MHb neuron subtype. Spatial distributions of enriched genes highlighted in (**C**) are labeled in red.](elife-51271-fig2){#fig2}

![Characterization of genes differentially expressed between LHb neuron subtypes.\
(**A**) Location of LHb clusters and ISH *Gap43* expression from the Allen Institute Database. *Gap43* is highly expressed in neurons of the LHb and surrounding thalamus in this region, but excluded from MHb neurons. (**B**) *Gap43* serves as an excellent marker for LHb neurons in the dataset of single-cell transcriptomes (Scale on right shows normalized (log) gene expression.) (**C**) Left: Illustration showing patterns of gene expression observed for DEGs. Right: Sample ISH images from the Allen Institute Database showing selected differentially expressed genes for distinct transcriptionally defined neuronal subtypes in LHb. (**D**) Left: Dendrogram with LHb neuron labels corresponding spatial locations of differentially expressed genes within the LHb. Right: Heatmap showing the relative expression of selected genes that are enriched in each LHb neuron subtype. Spatial distributions of enriched genes highlighted in (**C**) are labeled in red.](elife-51271-fig3){#fig3}

Differential gene expression reveals the spatial organization of MHb neuron subtypes {#s2-2}
------------------------------------------------------------------------------------

Analysis of MHb neurons revealed that they could be divided into eight clusters ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). However, three clusters were clearly distinguished by high expression of activity-dependent genes (ADGs) ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}), suggesting that they might simply reflect neurons of other clusters that had been recently strongly activated. Indeed, regressing out the PC containing a large number of ADGs ([Figure 2---figure supplement 1E--F](#fig2s1){ref-type="fig"}) caused these three high ADGs clusters to merge with other MHb clusters ([Figure 2---figure supplement 1C--D](#fig2s1){ref-type="fig"}), leaving five distinct subtypes of MHb neurons.

We constructed a cluster dendrogram using the averaged cluster gene expression to examine the transcriptional differences between these subtypes ([Figure 2D](#fig2){ref-type="fig"}). In general, subtypes of MHb neurons were divided by genes that were involved in the synthesis and packaging of different neurotransmitters and neuropeptides. All MHb neurons expressed high levels of *Slc17a6* and *Slc17a7,* the genes encoding vesicular glutamate transporters 1 and 2, and *Tac2* suggesting that all MHb neurons are glutamatergic and produce the neuropeptide Neurokinin B ([Figure 2D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Two of the five clusters also expressed *Slc18a3* and *Chat* (not shown), the vesicular transporter and biosynthetic enzyme for acetylcholine, respectively, indicating that these neurons may co-release glutamate and acetylcholine ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}), as has been described in several studies ([@bib39]; [@bib45]). Interestingly, no MHb neurons expressed significant levels of the canonical GABA handling genes *Slc32a1, Gad1,* or *Slc18a2* (although *Gad2* was expressed at low levels in all subtypes); therefore, they are unlikely to release GABA.

To examine the spatial distribution of MHb neuron subtypes we cross referenced their differentially expressed genes (DEGs) with the Allen Mouse Brain Atlas of ISH hybridization data ([Supplementary file 3](#supp3){ref-type="supplementary-material"}) ([@bib26]). Generally, we found that individual DEGs for particular MHb subtypes consistently mapped onto discrete regions in the MHb ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Also, DEGs for MHb neurons were rarely DEGs for LHb neurons ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). This permitted classification of transcriptionally defined MHb subtypes to particular subregions of MHb ([Figure 2D](#fig2){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). MHb neurons divided along the dorsal/ventral axis with a third lateral (enriched for genes *Sema3d, Calb1,* and *Spon1*) subtype ([Figure 2C--D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2C--E](#fig2s2){ref-type="fig"}). Ventral groups could be further subdivided into two distinct subtypes, the 'ventral two thirds' of the MHb (enriched for *Lmo3*) and the 'ventrolateral' MHb (enriched for genes *Esam* and *Slc18a3*). Gene expression patterns indicated that it is possible that neurons from these two subtypes were partially intermingled and did not form a defined border ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2A--B](#fig2s2){ref-type="fig"}). The rest of the MHb could be subdivided into the 'dorsal' (enriched for genes *Col16a1, Wif1,* and *Adcyap1*) and 'superior' (enriched for genes *Cck* and *Avil*) subtypes. These two groups split along a medial/lateral axis with the 'dorsal' being more laterally located than the 'superior' ([Figure 2C--D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2F--I](#fig2s2){ref-type="fig"}) ([@bib52]; [@bib51]).

Genetic distinction of four LHb neuron subtypes {#s2-3}
-----------------------------------------------

*Gap43* is highly expressed in the LHb and along with several other genes (*Htr2c*, *Pcdh10, Gabra1,* and *Syn2*) distinguishes neurons of this region from those of neighboring MHb ([Figure 3A--B](#fig3){ref-type="fig"}, [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Unlike for MHb neurons, we did not detect significant elevation of ADGs in LHb neurons. We found four distinct clusters of neurons in LHb which, again unlike MHb, did not have distinct expression profiles of genes involved in the synthesis and packaging of different typical fast neurotransmitters (e.g. glutamate, GABA, acetylcholine) -- all LHb neurons expressed high levels of *Slc17a6* and very low levels of *Slc32a1*, suggesting that they are glutamatergic.

Subdivisions of the lateral habenula based on topographic, morphological and cytochemical criteria have been described in rat ([@bib1]) and mouse ([@bib52]; [@bib51]) and are used here to describe the patterns of DEGs extracted from our single-cell dataset (see terms in quotes below). We examined the spatial distribution of LHb neuron subtypes by cross referencing their DEGs with the Allen Mouse Brain Atlas of ISH data ([@bib26]). We found that DEGs showed four distinct, but consistent patterns that aligned with their subclusters ([Figure 3C--D](#fig3){ref-type="fig"}). These consisted of 1) a cluster that showed high expression of DEGs in both the 'lateral oval' and 'central medial' subdivision, we named this the *oval/medial* subdivision; 2) a cluster that showed high expression of DEGs in the 'marginal subdivision of the medial division of the LHb', we called this the *marginal* subdivision; 3) a cluster that showed high expression of DEGs in the 'lateral' subdivision (but avoiding expression in the 'lateral oval'), we also called this the *lateral* subdivision; and 4) a cluster that showed high expression of DEGs in the subdivision defined as 'HbX' lying on the dorsal border between MHb and LHb, we also refer to this as the *HbX* subdivision ([Figure 3C](#fig3){ref-type="fig"}) ([@bib52]; [@bib51]). Interestingly, the *HbX* region is more closely related in its gene expression to other LHb clusters than to any clusters in the MHb; therefore, it is more similar to LHb neurons than previously recognized ([Figure 3D](#fig3){ref-type="fig"}) ([@bib52]).

We performed multiplexed FISH to confirm the four transcriptionally defined clusters of LHb neurons were distinct and to further examine their spatial organization within the LHb. We chose four highly expressed DEGs that represented each LHb cluster (*Chrm3, Vgf, Gpr151,* and *Sst*) and examined their expression in individual neurons ([Figure 4](#fig4){ref-type="fig"}). As predicted by the single-cell sequencing, the chosen genes generally expressed in different cells, confirming that they defined molecularly distinct neuronal subtypes ([Figure 4](#fig4){ref-type="fig"}). An exception to this general rule, but consistent with the predictions of single-cell sequencing, individual neurons in the HbX expressed both *Sst* and *Gpr151* ([Figure 4D](#fig4){ref-type="fig"}). Additionally, when strongly expressed, *Chrm3* and *Vgf* were found in different cells, but they were occasionally co-expressed in neurons that had relatively low levels of both genes ([Figure 4A](#fig4){ref-type="fig"}).

![FISH confirms that differentially expressed genes from LHb subclusters are nonoverlapping and confined to specific spatial locations of LHb.\
(**A**) Left: Sample FISH of two differentially expressed LHb genes (*Vgf* (yellow) and *Chrm3 (*magenta)), with distinct spatial profiles (LHb outlined with gray dashed line). Right: Quantification of fluorescence coverage of single cells for FISH of *Vgf* and *Chrm3* in LHb neurons (n = 444 cells, three mice). (**B**) Left: Sample FISH of two differentially expressed LHb genes (*Sst* (yellow) and *Chrm3 (*magenta)), with distinct spatial profiles. Right: Quantification of fluorescence coverage of single cells for FISH of *Sst* and *Chrm3* in LHb neurons (n = 252 cells, three mice). (**C**) Left: Sample FISH of two differentially expressed LHb genes (*Gpr151* (yellow) and *Chrm3 (*magenta)), with distinct spatial profiles (illustrated in upper right inset), LHb outlined in gray dashed line. Right: Quantification of fluorescence coverage of single cells for FISH of *Gpr151* and *Chrm3* in LHb neurons (n = 240 cells, three mice). (**D**) Left: Sample FISH of two differentially expressed LHb genes (*Sst* (yellow) and *Gpr151 (*magenta)), with similar spatial profiles (both expressed in HbX region). Inset of overlapping *Sst* and *Gpr151* expression in HbX. Right: Quantification of fluorescence coverage of single cells for FISH of *Sst* and *Gpr151* in LHb neurons (n = 112 cells, three mice).](elife-51271-fig4){#fig4}

The chosen genes are largely expressed in non-overlapping patterns at the macroscopic level, confirming the organization of LHb into molecularly defined subregions ([Figure 4](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). More specifically, cells expressing DEGs from different subtypes occupied distinct spatial domains along the medial/lateral axis of the LHb ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). However, cells from a subtype did intermingle with cells of another group and sharply defined borders between LHb subregions were not observed (e.g. [Figure 4C](#fig4){ref-type="fig"}). Therefore, diagrams of gene expression ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) illustrate where gene expression is greatest or where cells expressing the gene are most numerous and not that gene expression is perfectly restricted to a particular subregion. Furthermore, heterogeneity of gene expression across subregions was most pronounced in the middle of the anterior/posterior axis of the habenula (see [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and Methods).

To confirm that the gene expression patterns described above were representative of a subgroup rather than specific to those particular DEGs, we chose three additional DEGs form the oval/medial, marginal, and lateral subdivisions of the LHb (*Rbfox1, Plch1* and *Pbx3,* respectively, [Figure 3D](#fig3){ref-type="fig"}). Multichannel FISH for this second set of genes combined with the previous set confirmed that expression of DEGs from the same subgroup overlap both regionally, and in single cells ([Figure 4---figure supplements 2](#fig4s2){ref-type="fig"} and [3](#fig4s3){ref-type="fig"}). Importantly, we did not observe obvious gradients in expression along the medial/lateral axis for most of the DEGs using FISH; however, *Plch1* expression did decrease gradually for cells positioned more lateral within the LHb ([Figure 4---figure supplement 2E](#fig4s2){ref-type="fig"}).

LHb neuron subtypes differentially target VTA GABAergic and dopaminergic neurons {#s2-4}
--------------------------------------------------------------------------------

The LHb projects via the fasciculus retroflexus to the ventral tegmental area (VTA), rostromedial tegmental area (RMTg), and median/dorsal raphe ([@bib15]). The VTA consists of a large and diverse population of dopamine neurons, as well as smaller populations of purely GABAergic, purely glutamatergic, and GABA/glutamate coreleasing neurons. Both GABAergic and dopaminergic VTA neurons receive input from the LHb ([@bib3]; [@bib23]; [@bib34]; [@bib55]) but it is unknown if these arise from molecularly distinct LHb neurons. We tested if there was connectivity specificity between LHb and VTA neuronal subtypes using rabies virus-based monosynaptic retrograde tracing ([@bib56]). To examine LHb input to VTA GABAergic neurons we injected Cre-dependent TVA-mCherry into the VTA of a VGAT-IRES-Cre mouse to restrict initial rabies virus infection to GABAergic neurons. We also coinjected a Cre-dependent AAV encoding the rabies glycoprotein (RVG) to allow for retrograde monosynaptic transfer of G-deleted, pseudotyped, rabies virus (EnvA-RbV-GFP) ([Figure 5A](#fig5){ref-type="fig"}). As only neurons with Cre will express RVG, GFP-labeled neurons in other regions are putatively presynaptic to GFP+/RVG+ VTA neurons (see [Figure 5---figure supplement 2B](#fig5s2){ref-type="fig"} for controls for specificity of EnvA-RbV-GFP infection). FISH in the VTA revealed that \~ 30% of 'starter cells' (neurons that were GFP+ and Cre+), coexpressed *Slc17a6* (Vglut2) indicating they are likely GABA/glutamate coreleasing neurons ([Figure 5---figure supplement 2F](#fig5s2){ref-type="fig"}) ([@bib40]). The majority of the remaining 70% of 'starter cells' are purely GABAergic ([Figure 5---figure supplement 2F](#fig5s2){ref-type="fig"}).

![Distinct LHb neuron subtypes prefer different downstream targets, but all subtypes target both the VTA.\
(**A**) Location of site for AAV helper viruses (AAV-FLEX-TVA-mCh and AAV-FLEX-RVG) and pseudotyped rabies virus (EnvA-RbV-GFP) injection into VTA. (**B**) Sample habenula FISH images for *RbV-N* and *Chrm3* (top), *Vgf* (middle), or *Gpr151* (bottom) following viral injection into the VTA of a VGAT-IRES-Cre mouse. Arrow heads show *RbV-N+* cells coexpressing the DEG in each image. Histogram at bottom shows the distribution of the density of *RbV-N+* neurons along the medial lateral axis of LHb (n = 822 cells/4 animals). (**C**) Sample habenula FISH images for *RbV-N* and *Chrm3* (top), *Vgf* (middle), or *Gpr151* (bottom) following viral injection into the VTA of a DAT-IRES-Cre mouse. Arrow heads show *RbV-N+* cells coexpressing the DEG in each image. Histogram at bottom shows the distribution of the density of *RbV-N+* neurons along the medial lateral axis of LHb (n = 299 cells/3 animals). (**D**) Quantification of the proportion of *RbV-N* labeled neurons that overlapped with the enriched genes for distinct LHb neuron subtypes (VGAT-IRES-Cre n = 1430 cells/ four mice and DAT-IRES-Cre n = 549/3 mice). Filled rectangles are the mean and error bars are ± SEM, see [Supplementary file 6](#supp6){ref-type="supplementary-material"} for statistical comparisons.](elife-51271-fig5){#fig5}

Using FISH we found retrogradely labeled neurons, marked by expression of *RbV-N* mRNA, in all four LHb subtypes (identified using enriched genes *Chrm3, Vgf, Gpr151,* and *Sst*) ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). The majority of retrogradely labeled LHb neurons were found in the lateral and oval/medial subtypes in roughly equal proportions (mean ± SEM: 48 ± 0.5% *Gpr151+* and 41 ± 0.6% *Chrm3+*, respectively) ([Figure 5D](#fig5){ref-type="fig"}). A much smaller proportion was found in the marginal subtype (10 ± 1% *Vgf+*), and very few HbX neurons (2 ± 1% *Sst+*) were retrogradely labeled. As a population, the distribution of retrogradely labeled cells was skewed laterally along the medial/lateral axis of the LHb ([Figure 5B](#fig5){ref-type="fig"}).

To examine LHb input to VTA dopaminergic neurons we performed monosynaptic retrograde tracing using the same series of viral injections in DAT-IRES-Cre mice ([Figure 5A](#fig5){ref-type="fig"}). FISH in the VTA revealed that \~9% of 'starter cells' (neurons that were GFP+ and Cre+), coexpressed *Slc32a1* (VGAT) and *Slc6a3* (dopamine transporter, DAT) indicating they are dopaminergic neurons that also express *Slc32a1* ([Figure 5---figure supplement 2G](#fig5s2){ref-type="fig"}) ([@bib34]; [@bib49]). The remaining 91% of starter cells express only *Slc6a3* indicating low levels of starter cell overlap with the experiments done in the VGAT-IRES-Cre line ([Figure 5---figure supplement 2F](#fig5s2){ref-type="fig"}). We performed FISH on retrogradely labeled neurons in the LHb and found that a much larger proportion of retrogradely labeled neurons in the oval/medial and marginal subtypes (61 ± 2% *Chrm3+* and 20 ± 1% *Vgf+,* respectively) in the DAT-IRES-Cre than the VGAT-IRES-Cre line ([Figure 5B--D](#fig5){ref-type="fig"}). Consequently, a smaller proportion of neurons in the lateral subtype were labeled (10 ± 0.4% *Gpr151+*) and almost no neurons in the HbX subregion were labeled (0.7 ± 0.5% *Sst+*) ([Figure 5D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). In contrast to the results from injections into VGAT-IRES-Cre mice, the retrogradely labeled cells from injections into DAT-IRES-Cre mice were distributed relatively evenly along the medial/lateral axis of the LHb ([Figure 5C](#fig5){ref-type="fig"}). Together these data suggest that both VTA GABAergic and dopaminergic neurons can receive input from all four subtypes of LHb neuron. However, VTA dopaminergic neurons receive the largest proportion of their LHb input from the oval/medial LHb subtype, whereas VTA GABAergic neurons receive equal levels of input from both the oval/medial and lateral LHb subtypes ([Supplementary file 6](#supp6){ref-type="supplementary-material"}). Furthermore, the LHb input to VTA GABAergic neurons is skewed laterally in the LHb, while input to dopamine neurons is evenly distributed along the medial/lateral axis ([Figure 5B--C](#fig5){ref-type="fig"}).

All LHb neuron subtypes project to the DRN in proportions similar to VTA dopamine neurons {#s2-5}
-----------------------------------------------------------------------------------------

LHb neurons heavily innervate the dorsal and median raphe nuclei (DRN/MRN) and modulate serotonergic output throughout the brain ([@bib62]; [@bib64]). To examine the LHb subtypes that project to the DRN, we injected a non-pseudotyped G-deleted rabies virus (RbV-GFP) into this area and performed FISH in the LHb for subtype enriched genes ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). Importantly, non-pseudotyped G-deleted rabies virus does infect axons but does not spread across synapses formed onto the infected cell due to deletion of the rabies glycoprotein (G). Also, as this virus is not pseudotyped, TVA is not needed for infection and the virus acts in a similar way to many other retrograde tracers -- but one whose signal we can amplify by performing FISH for the viral gene *RbV-N*. Similar to dopaminergic VTA neurons, the DRN received the largest proportion of its LHb input from the oval/medial subtype (51 ± 2% *Chrm3+*) ([Figure 5---figure supplement 3D](#fig5s3){ref-type="fig"}). The DRN also received minor inputs from the lateral (16 ± 5% *Gpr151+*), marginal (28 ± 5% *Vgf+*), and HbX (1 ± 0.5% *Sst+*) regions ([Figure 5---figure supplement 3D](#fig5s3){ref-type="fig"}). Overall, the proportions of input to the DRN arising from different LHb subtypes were more similar to those to VTA dopamine neurons than those to VTA GABA neurons ([Figure 5---figure supplement 3D](#fig5s3){ref-type="fig"}, [Supplementary file 6](#supp6){ref-type="supplementary-material"}). However, the distribution of LHb input to DRN has a prominent spike on the medial edge of the LHb indicating that large proportion of the LHb input to DRN is located in this area ([Figure 5---figure supplement 3B and D](#fig5s3){ref-type="fig"}). Therefore, the LHb neurons are grossly organized along the medial/lateral axis based on their projection target: the most medial LHb neurons preferentially target the DRN, whereas the most lateral LHb neurons preferentially target VTA GABA neurons. Finally, input to VTA DA neurons is distributed relatively evenly along the medial/lateral axis of the LHb ([Figure 5---figure supplement 3D](#fig5s3){ref-type="fig"}).

Discussion {#s3}
==========

We performed transcriptional and anatomical analyses of the habenula, a crucial circuit node that modifies brain-wide dopamine and serotonin levels through its connections to the VTA and DRN ([@bib36]; [@bib48]; [@bib62]). Using large-scale single-cell transcriptional profiling, we classify MHb and LHb neurons into five and four major neuron types, respectively, and show that each class has a distinct gene expression pattern. The four LHb populations were confirmed to be non-overlapping at the single-cell level by FISH. Monosynaptic retrograde tracing revealed that GABAergic VTA neurons receive equal input from the oval/medial and lateral LHb neuronal subtypes, whereas dopaminergic VTA neurons receive input primarily from the oval/medial LHb subtype. Neurons of the DRN receive input from similar LHb cell-types in roughly similar proportions to dopaminergic VTA neurons; however, the LHb cells that target the DRN are skewed medially compared to the cells that target either dopaminergic or GABAergic cells of the VTA.

Anatomical distribution of MHb neuronal subtypes {#s3-1}
------------------------------------------------

Recent studies have identified and delineated the subnuclei of the mouse MHb using morphological, topographic and cytochemical criteria ([@bib52]; [@bib51]). Using single-cell transcriptional profiling, we show that MHb neurons can be categorized into subtypes based on differential gene expression. Furthermore, the spatial distribution of these transcripts allowed us to ascribe an anatomical location to each subtype. The anatomical location of these subtypes largely agree with previously defined MHb subnuclei and we have used the same nomenclature when possible ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) ([@bib52]).

The two ventral subtypes of the MHb coexpressed transcripts for glutamate and ACh neurotransmission ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Our data suggest these two ventral subtypes can be differentially targeted with intersectional approaches, as genes such as *Lmo3* and *Esam* are preferentially expressed in one subtype ([Figure 2D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Previous studies indicate that MHb neurons that release glutamate and ACh target the medial interpeduncular nucleus (IPN) ([@bib39]) and are involved in the formation of aversive memories ([@bib45]). However, whether one or both of the transcriptionally defined subtypes are involved in this process is unknown.

Additionally, cholinergic transmission in MHb has also been implicated in nicotine addiction as MHb neurons not only release ACh, but express an array of nicotinic acetylcholine receptor subunits (nAChRs, such as *Chrna3* and *Chrnb3;* [Figure 2---figure supplements 2](#fig2s2){ref-type="fig"} and [6](#fig2s6){ref-type="fig"}) ([@bib12]; [@bib44]). Similar to its involvement in aversive memories, MHb likely plays an important role in mediating the unpleasant symptoms associated with nicotine withdrawal ([@bib63]). Our data provide a comprehensive view of all nAChR and mAChR transcripts expressed in both MHb and LHb providing a resource for the development of new therapeutic targets for the treatment of addiction ([Figure 2---figure supplements 6](#fig2s6){ref-type="fig"}--[8](#fig2s8){ref-type="fig"}) ([@bib10]; [@bib66]).

Few studies have examined the function of the dorsal (enriched for genes *Col16a1, Wif1,* and *Adcyap1*) and superior (enriched for genes *Cck,* and *Avil*) MHb. These neurons were known to express high levels of *Tac1* (the gene that produces the neuropeptide substance P), consistent with our single-cell sequencing data ([Figure 2---figure supplement 2J](#fig2s2){ref-type="fig"}) and target the lateral IPN ([@bib19]). Their activation may be reinforcing ([@bib18]), but detailed analysis of their function and neurotransmitter release has not been examined.

LHb neuronal subtypes {#s3-2}
---------------------

We referenced recent studies on LHb subnuclei to create a map ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) of LHb based on DEGs extracted from single-cell transcriptional profiling ([@bib52]; [@bib51]). Overall, our map largely agrees with previous work and adds many key observations into the organization and cellular and molecular diversity of the LHb. In addition to providing multiple genetic handles that can be used in future studies to target LHb neuron subtypes, our study reveals the a wide range of GPCRs (such as *Htr2c, Htr5b, Sstr2, Cnr1, Gpr158, Lpar1, Adcyap1r1*; see [Figure 2---figure supplement 8](#fig2s8){ref-type="fig"}) expressed in LHb neurons that could be targeted for treatment of diseases known to effect LHb function such as depression, anxiety, and addiction ([@bib24]; [@bib36]). In contrast to some reports ([@bib61]), we did not find evidence of GABAergic neurons in the LHb (or MHb). Although *Gad2* and *Slc6a1*, which encode a GABA synthetic enzyme and GABA transporter, respectively, were present at low levels in all LHb clusters we did not find expression of *Slc32a1* or *Slc18a2*, which are required for vesicular loading of GABA ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). This is in agreement with recently published results demonstrating that *Gad2* expression is a poor discriminator for inhibitory (GABAergic) neurons ([@bib33]; [@bib41]). Therefore, either LHb GABAergic cells are rare enough to be missed in the single-cell sequencing, or the habenula is devoid of GABAergic neurons.

We used *Gpr151* expression (as well as *Pbx3* expression) to mark the lateral region of the LHb. The *Gpr151*+ neurons of the lateral LHb are the most well-studied neuronal subtype in the LHb and they receive major input from the lateral preoptic area, lateral hypothalamus, entopeduncular nucleus (EP), basal nucleus of the stria terminalis, and the nucleus of the diagonal band ([@bib5]). These neurons also receive a minor input from the VTA, and are positioned to receive GABA/glutamate coreleasing input from both the EP and VTA ([@bib40]; [@bib53]). *Gpr151*+ axons, likely arriving from the LHb, heavily innervate the RMTg and central and median raphe nucleus, but not the VTA ([@bib4]). Our retrograde-tracing studies from VTA neurons show that *Gpr151+* neurons tend to avoid dopaminergic VTA neurons, but heavily innervated the intermingled GABAergic neurons in this brain region ([Figure 5](#fig5){ref-type="fig"}). VTA GABAergic interneurons are functionally similar to inhibitory RMTg neurons (both populations inhibit VTA dopaminergic neurons \[[@bib7]; [@bib21])\], consistent with our results that both are innervated by lateral LHb. Furthermore, the lateral LHb is likely the major LHb subtype to translate aversive signals to VTA GABAergic neurons which become active following reward omission due to increased LHb input ([@bib48]). Overall, these cells are positioned to translate signals arriving from EP to downstream midbrain structures involved in both dopamine and serotonin signaling.

The oval/medial subregion of the LHb expresses high levels of *Chrm3* (as well as *Rbfox1*). Our previous studies indicate that this subtype is positioned to receive purely glutamatergic input from *Pvalb+/Slc16a7+* EP neurons that specifically target the lateral oval nucleus of the LHb ([@bib53]). Additionally, GABA/glutamate coreleasing EP neurons target the lateral oval (as well as the neighboring *Gpr151+* lateral LHb) providing overlapping, but differential EP input to this subregion ([@bib53]). Electrophysiological analysis has also shown preferential input from EP to the lateral half of LHb, specifically, to the neurons that project to RMTg ([@bib31]).

In addition to VTA GABAergic neurons, LHb targets meso-prefrontal VTA dopamine neurons while avoiding other (mesolimbic and nigral) dopamine neurons ([@bib23]). We found that the majority of LHb neurons that projected to VTA dopamine neurons expressed *Chrm3,* a gene enriched in the oval/medial subregion. Furthermore, the distribution of retrogradely labeled LHb neurons that project to VTA dopamine neurons is shifted medially compared to the distribution of those that project to VTA GABA neurons, indicating that VTA dopamine projecting *Chrm3+* LHb neurons reside primarily in the more medial part of the oval/medial subdivision ([Figure 5B--C](#fig5){ref-type="fig"}). This is consistent with studies that suggest that LHb neurons that target the VTA dopamine neurons may be distinct from those that target the RMTg; therefore, two populations of *Chrm3+* LHb neurons with different synaptic targets may exist ([@bib23]; [@bib27]; [@bib29]). Additional genetic heterogeneity between *Chrm3+* oval and medial subdivisions could be further resolved with higher resolution sequencing methods ([@bib2]; [@bib47]). Nevertheless, our data show that VTA dopamine, and VTA GABAergic neurons are positioned to receive quite different synaptic input from the LHb due to their differential targeting by LHb neuronal subtypes.

The marginal subdivision of the LHb was enriched for *Vgf* and *Plch1* ([Figure 4](#fig4){ref-type="fig"} and [Figure 4---figure supplements 2](#fig4s2){ref-type="fig"}--[3](#fig4s3){ref-type="fig"}). Our retrograde-tracing studies revealed that this subregion projects most heavily to the DRN, and the distribution of LHb input to DRN has a prominent spike on the medial edge of the LHb ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). This finding is in agreement to other studies showing labeling of the medial half of the LHb following injections of retrograde tracers into the raphe nucleus ([@bib25]; [@bib37]; [@bib46]). Interestingly, this region also appears to also receive dense input from serotonergic neurons of the raphe nuclei ([@bib20]), and express *Htr2c* as well as several other serotonin receptors ([Figure 2---figure supplement 8](#fig2s8){ref-type="fig"}). We expect that this subregion also projects heavily to the lateral dorsal tegmental nucleus (LDTg) and posterior hypothalamic area (PH), as retrograde injections into these areas exclusively label the medial half of the LHb ([@bib37]).

Summary {#s3-3}
-------

Progress in defining a function for the habenula has been hindered by incomplete understanding of its constituent cell-types and subregions. This study provides a comprehensive description of the neuronal classes in the lateral and medial habenula based on single-cell transcriptional profiling, FISH, and monosynaptic retrograde tracing ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Future studies will improve our understanding of the function of these habenula cell types by employing current optogenetic, chemogenetic, and electrophysiological approaches for precise control and monitoring of individual habenular populations.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                              Designation                                                  Source or reference                                              Identifiers                                                               Additional\
  (species) or resource                                                                                                                                                                                                                                              information
  ---------------------------------------------------------- ------------------------------------------------------------ ---------------------------------------------------------------- ------------------------------------------------------------------------- -----------------------------------------------------------------
  Strain (*Mus musculus*)                                    C57Bl/6J                                                     The Jackson Laboratory                                           Cat\# JAX:000664\                                                         
                                                                                                                                                                                           RRID: [IMSR_JAX:000664](https://scicrunch.org/resolver/IMSR_JAX:000664)   

  Genetic reagent (*Mus musculus*)                           VGAT-IRES-Cre                                                The Jackson Laboratory                                           Cat\# JAX: 016962\                                                        
                                                                                                                                                                                           RRID: [IMSR_JAX:016962](https://scicrunch.org/resolver/IMSR_JAX:016962)   

  Genetic reagent (*Mus musculus*)                           DAT-IRES-Cre                                                 The Jackson Laboratory                                           Cat\# JAX: 006660\                                                        
                                                                                                                                                                                           RRID: [IMSR_JAX:006660](https://scicrunch.org/resolver/IMSR_JAX:006660)   

  Genetic reagent (non-pseudotyped G-deleted rabies virus)   B19-SADdG-\                                                  Other                                                            N/A                                                                       Generated in-house (see Materials and methods) 10^9^ IU/mL
                                                             EGFP, RbV-GFP                                                                                                                                                                                           

  Genetic reagent (pseudotyped G-deleted rabies virus)       EnvA-RbV-GFP                                                 Janelia Viral\                                                   Addgene\# 52487\                                                          10^8^ IU/mL
                                                                                                                          Tools facility                                                   RRID: [Addgene_52487](https://scicrunch.org/resolver/Addgene_52487)       

  Commercial assay, kit                                      RNAscope V1 fluorescent multiplex detection assay reagents   ACDBio                                                           Cat\#320851                                                               

  Commerical assay, kit                                      RNAscope V1 fluorescent multiplex detection assay probes     ACDBio                                                           Cat\# 456781\                                                             *V-RABV-gp1*\
                                                                                                                                                                                           Cat\# 317321\                                                             *Gpr151*\
                                                                                                                                                                                           Cat\# 404631\                                                             *Sst*\
                                                                                                                                                                                           Cat\# 556241\                                                             *Plch1*\
                                                                                                                                                                                           Cat\# 436381\                                                             *Pbx3*\
                                                                                                                                                                                           Cat\# 519911\                                                             *Rbfox1*\
                                                                                                                                                                                           Cat\# 437701\                                                             *Chrm3*\
                                                                                                                                                                                           Cat\# 517421\                                                             *Vgf*\
                                                                                                                                                                                           Cat\# 423321\                                                             *Cre*\
                                                                                                                                                                                           Cat\# 319171\                                                             *Slc17a6*\
                                                                                                                                                                                           Cat\# 319191\                                                             *Slc32a1*\
                                                                                                                                                                                           Cat\# 315441                                                              *Slc6a3*

  Software, algorithm                                        inDrops pipeline\                                            PMID: [26000487](https://www.ncbi.nlm.nih.gov/pubmed/26000487)   N/A                                                                       <https://github.com/indrops/indrops>
                                                             (Python)                                                                                                                                                                                                

  Software, algorithm                                        R 3.4.4                                                      R project for statistical computing                              RRID:[SCR_001905](https://scicrunch.org/resolver/SCR_001905)              <https://cran.r-project.org/>

  Software, algorithm                                        Seurat 2.3.4                                                 PMID: [29608179](https://www.ncbi.nlm.nih.gov/pubmed/29608179)   RRID:[SCR_016341](https://scicrunch.org/resolver/SCR_016341)              <https://satijalab.org/seurat/>

  Software, algorithm                                        MAST 1.4.1                                                   PMID: [26653891](https://www.ncbi.nlm.nih.gov/pubmed/26653891)   RRID:[SCR_016340](https://scicrunch.org/resolver/SCR_016340)              <https://bioconductor.org/packages/release/bioc/html/MAST.html>

  Software, algorithm                                        MATLAB (R2015a)                                              MathWorks                                                        RRID:[SCR_001622](https://scicrunch.org/resolver/SCR_001622)              

  Software, algorithm                                        Fiji                                                         PMID: [22743772](https://www.ncbi.nlm.nih.gov/pubmed/22743772)   RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)              <https://imagej.net/Fiji>
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mice {#s4-1}
----

The following mouse strains/lines were used in this study: C57BL/6J (The Jackson Laboratory, Stock \# 000664), VGAT-IRES-Cre (The Jackson Laboratory, Stock \# 016962), DAT-IRES-Cre (The Jackson Laboratory, Stock \# 006660) (for reference, VGAT gene name is *Slc32a1* and DAT gene name is *Slc6a3*). Animals were kept on a 12:12 regular light/dark cycle under standard housing conditions. All procedures were performed in accordance with protocols approved by the Harvard Standing Committee on Animal Care following guidelines described in the U.S. National Institutes of Health Guide for the Care and Use of Laboratory Animals.

Adeno-associated viruses (AAVs) {#s4-2}
-------------------------------

Recombinant AAVs used for retrograde tracing experiments (AAV2/9-CAG-FLEX-TCB-mCherry, AAV2/9-CAG-FLEX-RVG) were commercially obtained from the Boston Children's Hospital Viral Core (Addgene \# 48332 and 48333, respectively). Virus aliquots were stored at −80°C, and were injected at a concentration of approximately 10^11^ or 10^12^ GC/ml, respectively. Controls for the specificity of AAV2/9-CAG-FLEX-TCB-mCherry for cells expressing Cre are included in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}.

Rabies viruses {#s4-3}
--------------

Pseudotyped rabies virus (EnvA-RbV-GFP, SAD B19 strain, Addgene\# 52487) was commercially obtained from the Janelia Viral Tools Facility stored at −80°C, and injected at a concentration of approximately 10^8^ IU/ml. Controls showing the requirement of TVA for EnvA-RbV-GFP infection are included in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}. Non-pseudotyped (G-deleted) rabies viruses used for retrograde tracing (RbV-GFP) were generated in-house ([@bib57]). Virions were amplified from existing stocks in three rounds of low-MOI passaging through BHK-B19G cells by transfer of filtered supernatant, with 3 to 4 days between passages. Cells were grown at 35°C and 5% CO~2~ in DMEM with GlutaMAX (Thermo Scientific, \#10569010) supplemented with 5% heat-inactivated FBS (Thermo Scientific \#10082147) and antibiotic-antimycotic (Thermo Scientific \#15240--062). Virions were concentrated from media from dishes containing virion-generating cells by first collecting and incubating with benzonase nuclease (1:1000, Millipore \#70664) at 37°C for 30 min, followed by filtration through a 0.22 µm PES filter. The filtered supernatant was transferred to ultracentrifuge tubes (Beckman Coulter \#344058) with 2 ml of 20% sucrose in dPBS cushion and ultracentrifugated at 20,000 rpm (Beckman Coulter SW 32 Ti rotor) at 4°C for 2 hr. The supernatant was discarded and the pellet was resuspended in dPBS for 6 hr on an orbital shaker at 4°C before aliquots were prepared and frozen for long-term storage at −80°C. Nonpseudotyped rabies virus titers were estimated based on a serial dilution method counting infected HEK 293 T cells, and quantified as infectious units per ml (IU/ml).

Stereotaxic surgeries {#s4-4}
---------------------

Adult mice were anesthetized with isoflurane (5%) and placed in a small animal stereotaxic frame (David Kopf Instruments). After exposing the skull under aseptic conditions, viruses were injected through a pulled glass pipette at a rate of 50 nl/min using an UMP3 microsyringe pump (World Precision Instruments). Pipettes were slowly withdrawn (\<100 µm/s) at least 10 min after the end of the infusion. Following wound closure, mice were placed in a cage with a heating pad until their activity was recovered before returning to their home cage. Mice were given pre- and post-operative subcutaneous ketoprofen (10 mg/kg/day) as an analgesic, and monitored daily for at least 4 days post-surgery. Injection coordinates from Bregma for VTA were −3.135 mm A/P, 0.4 mm M/L, and 4.4 mm D/V and for DRN were −6.077 mm A/P, 0.1 mm M/L, and −3.33 mm D/V at −40°. Injection volumes for specific anatomical regions and virus types were as follows VTA: 200 nL AAV (mix of helper viruses), 250 nL EnvA-RbV-GFP (21 days after injection of AAV), DRN: 300 nL of RbV-GFP. Animals injected with rabies virus were perfused 7 days after injection in a biosafety level two animal facility.

Single-cell dissociation and RNA sequencing {#s4-5}
-------------------------------------------

Eight- to 10-week-old C57BL/6J mice were pair-housed in a regular 12:12 light/dark cycle room prior to tissue collection. Mice were transcardially perfused with an ice-cold choline cutting solution (110 mM choline chloride, 25 mM sodium bicarbonate, 12 mM D-glucose, 11.6 mM sodium L-ascorbate, 10 mM HEPES, 7.5 mM magnesium chloride, 3.1 mM sodium pyruvate, 2.5 mM potassium chloride, 1.25 mM sodium phosphate monobasic, saturated with bubbling 95% oxygen/5% carbon dioxide, pH adjusted to 7.4 using sodium hydroxide). Brains were rapidly dissected out and sliced into 200-µm-thick coronal sections on a vibratome (Leica Biosystems, VT1000) with a chilled cutting chamber filled with choline cutting solution. Coronal slices containing the habenula were then transferred to a chilled dissection dish containing a choline-based cutting solution for microdissection. Dissected tissue chunks were transferred to cold HBSS-based dissociation media (Thermo Fisher Scientific Cat. \# 14170112, supplemented to final content concentrations: 138 mM sodium chloride, 11 mM D-glucose, 10 mM HEPES, 5.33 mM potassium chloride, 4.17 mM sodium bicarbonate, 2.12 mM magnesium chloride, 0.441 mM potassium phosphate monobasic, 0.338 mM sodium phosphate monobasic, saturated with bubbling 95% oxygen/5% carbon dioxide, pH adjusted to 7.35 using sodium hydroxide) and kept on ice until dissections were completed. Dissected tissue chunks for each sample were pooled for each hemisphere for the subsequent dissociation steps. Tissue chunks were first mixed with a digestion cocktail (dissociation media, supplemented to working concentrations: 20 U/ml papain, 0.05 mg/mL DNAse I) and incubated at 34°C for 90 min with gentle rocking. The digestion was quenched by adding dissociation media supplemented with 0.2% BSA and 10 mg/ml ovomucoid inhibitor (Worthington Cat. \# LK003128), and samples were kept chilled for the rest of the dissociation procedure. Digested tissue was collected by brief centrifugation (5 min, 300 *g*), re-suspended in dissociation media supplemented with 0.2% BSA, 1 mg/ml ovomucoid inhibitor, and 0.05 mg/mL DNAse I. Tissue chunks were then mechanically triturated using fine-tip plastic micropipette tips of progressively decreasing size. The triturated cell suspension was filtered through a 40 µm cell strainer (Corning 352340) and washed in two repeated centrifugation (5 min, 300 *g*) and re-suspension steps to remove debris before a final re-suspension in dissociation media containing 0.04% BSA and 15% OptiPrep (Sigma D1556). Cell density was calculated based on hemocytometer counts and adjusted to approximately 100,000 cells/ml. Single-cell encapsulation and RNA capture on the InDrop platform was performed at the Harvard Medical School ICCB Single Cell Core using v3 chemistry hydrogels based on previously described protocols ([@bib65]). Suspensions were kept chilled until the cells were flowed into the microfluidic device. Libraries were prepared and indexed following the protocols referenced above, and sequencing-ready libraries were stored at −80°C. Libraries from different samples were pooled and sequenced on an Illumina NextSeq 500 (High Output v2 kits).

Sequencing data processing {#s4-6}
--------------------------

NGS data was processed using previously a published pipeline in Python available at \[<https://github.com/indrops/indrops>\] ([@bib22]). Briefly, reads were filtered by expected structure and sorted by the corresponding library index. Valid reads were then demultiplexed and sorted by cell barcodes. Cell barcodes containing fewer than 250 total reads were discarded, and remaining reads were aligned to a reference mouse transcriptome (Ensembl GRCm38 release 87) using Bowtie 1.1.1 (m = 200, n = 1, l = 15, e = 1000). Aligned reads were then quantified as UMI-filtered mapped read (UMIFM) counts. UMIFM counts and quantification metrics for each cell were combined into a single file sorted by library and exported as a gunzipped TSV file.

Pre-clustering filtering and normalization {#s4-7}
------------------------------------------

Analysis of the processed NGS data was performed in R (version 3.4.4) using the Seurat package (version 2.3.4) ([@bib6]; [@bib42]). Cells with fewer than 500 UMIFM counts and 200 genes were removed. The expression data matrix (Genes x Cells) was filtered to retain genes with \>5 UMIFM counts, and then loaded into a Seurat object along with the library metadata for downstream processing. The percentage of mitochondrial transcripts for each cell (percent.mito) was calculated and added as metadata to the Seurat object. Cells in the object were further filtered using the following parameters: nUMI -- min. 500, max. 18000; nGene -- min. 200, max. 6000; percent.mito -- min. -Inf, max. 0.1. Low-quality libraries identified as outliers on scatter plots of quality control metrics (e.g. unusually low gradient on the nGene vs. nUMI) were also removed from the dataset. Filtered Seurat objects were then log-normalized at 10,000 transcripts per cell. Effects of latent variables (nUMI, percent.mito) were estimated and regressed out using a GLM (`ScaleData` function, `model.use` = '`linear`'), and the scaled and centered residuals were used for dimensionality reduction and clustering. Raw data and the normalized, filtered, scaled, R object can be found at Harvard Dataverse here: <https://doi.org/10.7910/DVN/2VFWF6>.

Cell clustering and cluster identification {#s4-8}
------------------------------------------

Initial clustering was performed on the dataset using the first 20 PCs, and t-SNE was used only for data visualization. Clustering was run using the SNN-based `FindClusters` function using the SLM algorithm and 10 iterations. Clustering was performed at varying resolution values, and we chose a final value of 1.2 for the resolution parameter for this stage of clustering. Clusters were assigned preliminary identities based on expression of combinations of known enriched genes for major cell classes and types. The full list of enriched genes is provided in [Supplementary file 2](#supp2){ref-type="supplementary-material"} and average expression of all genes in all clusters is provided in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. Low quality cells were identified based on a combination of low gene/UMIFM counts and high levels of mitochondrial and nuclear transcripts (e.g. *Malat1*, *Meg3*, *Kcnq1ot1*) typically clustered together and were removed. Following assignment of preliminary identities, cells were divided into data subsets as separate Seurat objects (LHb neurons and MHb neurons) for further subclustering. The expression matrix for each data subset was further filtered to include only genes expressed by the cells in the subset (minimum cell threshold of 0.5% of cells in the subset). Subclustering was performed iteratively on each data subset to resolve additional cell types and subtypes. Briefly, clustering was run at high resolution, and the resulting clusters were ordered in a cluster dendrogram using the `BuildClusterTree` function in Seurat which uses cluster averaged PCs for calculating a PC distance matrix. Putative doublets/multiplets were identified based on expression of known enriched genes for different cell types not in the cell subset (e.g. neuronal and glial-specific genes). Putative doublets tended to separate from other cells and cluster together, and these clusters were removed from the dataset. Cluster separation was evaluated using the `AssessNodes` function and inspection of differentially expressed genes at each node. Clusters with poor separation, based differential expression of mostly housekeeping genes, or activity dependent genes (see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) were merged to avoid over-separation of the data. The dendrogram was reconstructed after merging or removal of clusters, and the process of inspecting and merging or removing clusters was repeated until all resulting clusters could be distinguished based on a set of differentially expressed genes that we could validate separately. To calculate the 'ADG Score' ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), we used the `AddModuleScore` function in Seurat using a list of ADGs that were highly expressed in some of the MHb clusters (*Fos, Fosb, Egr1, Junb, Nr4a1, Dusp18, Jun, Jund*).

Differential expression tests {#s4-9}
-----------------------------

Tests for differential gene expression were performed using MAST (version 1.10.1) ([@bib11]) through the `FindMarkersNode` function in Seurat (`logfc.threshold = 0.25, min.pct = 0.1`). Adjusted *P* values were corrected using the Bonferroni correction for multiple comparisons (p\<0.05).

Fluorescence in-situ hybridization (FISH) {#s4-10}
-----------------------------------------

Mice were deeply anesthetized with isoflurane, decapitated, and their brains were quickly removed and frozen in tissue freezing medium on dry ice. Brains were cut on a cryostat (Leica CM 1950) into 30 µm sections, adhered to SuperFrost Plus slides (VWR), and immediately refrozen. Samples were fixed 4% paraformaldehyde and processed according to ACD RNAscope Fluorescent Multiplex Assay manual. Sections were incubated at room temperature for 30 s with DAPI, excess liquid was removed, and immediately coverslipped with ProLong antifade reagent (Molecular Probes). Antisense probes for *RbV-N, Gpr151, Sst, Plch1, Pbx3, Rbfox1, Chrm3, Vgf, Cre, Slc17a6, Slc32a1, and Slc6a3* were purchased from Advanced Cell Diagonstics (ACD, <http://acdbio.com/>). Sections were imaged at 1920 × 1440 pixels on a Keyence BZ-X710 fluorescence microscope using a 10X, 0.45 NA air Nikon Plan Apo objective. Individual imaging planes were overlaid and quantified for colocalization in ImageJ (NIH) and Matlab (Mathworks).

Image analysis {#s4-11}
--------------

FISH images were analyzed for 'fluorescence coverage (%)," meaning the proportion of fluorescent pixels to total pixels in a cellular ROI, using a custom macro in Image J and custom scripts in Matlab ([Figure 4](#fig4){ref-type="fig"}, [Figure 4---figure supplements 2](#fig4s2){ref-type="fig"}--[3](#fig4s3){ref-type="fig"}, and [Figure 5---figure supplements 1](#fig5s1){ref-type="fig"}--[3](#fig5s3){ref-type="fig"}). 5--10 images from at least three mice were analyzed for each condition. Cell ROIs were automatically determined based on fluorescence signals in all three channels (or by fluorescence in the *RbV-N* channel for rabies tracing experiments), and manually adjusted prior to analysis to ensure that all cell ROIs reflected individual cells and not clusters. After background subtraction (the signal outside of cell ROIs) and application of a fluorescence threshold (Renyi Entropy), the amount of fluorescent pixels in each optical channel was counted within the cellular ROI. All images compared underwent identical thresholding and no other manipulations were made. These data were used to generate X-Y plots displaying the percent coverage for each channel per cell ([Figure 4](#fig4){ref-type="fig"}, [Figure 4---figure supplements 2](#fig4s2){ref-type="fig"}--[3](#fig4s3){ref-type="fig"}, and [Figure 5---figure supplements 1](#fig5s1){ref-type="fig"}--[3](#fig5s3){ref-type="fig"}). For all histograms of media/lateral position of cells ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}, [Figure 5](#fig5){ref-type="fig"}, and [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}), a subset of images were chosen that excluded the anterior and posterior poles of the habenula (images included spanned approximately −1.655 to −1.855 A/P from bregma). The anterior and posterior poles of the LHb were excluded for this analysis because the subregions described in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} did not persist. Images including the anterior and posterior poles of the habenula were included for all other analysis except for these histograms.
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The following dataset was generated:

MichaelWallace2019Wallace_etal_2019_habenula_scseqHarvard Dataverse10.7910/DVN/2VFWF6

10.7554/eLife.51271.sa1

Decision letter

Lobo

Mary Kay

Reviewing Editor

University of Maryland

United States

Lobo

Mary Kay

Reviewer

University of Maryland

United States

Mameli

Manuel

Reviewer

The University of Lausanne

Switzerland

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This study provides a new and detailed molecular characterization of medial and lateral habenula cell subtypes. This analysis occurs at the anatomical and projection targeting levels using an array of modern approaches including single cell sequencing, FISH, and mononsynaptic tracing. The authors provide new information into molecular identities of lateral and medial habenula cell subtypes that are organized into anatomical subregions. They further show that lateral habenula anatomical neuron populations display distinct targeting to dopaminergic and GABAergic neurons in the ventral tegmental area. This is a timely study that provides a valuable resource for researchers studying habenula cell subtypes.

**Decision letter after peer review:**

Thank you for submitting your article \"Distinct neuronal subtypes of the lateral habenula differentially target ventral tegmental area dopamine neurons\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Mary Kay Lobo as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Kate Wassum as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Manuel Mameli (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Essential revisions:

The reviewers raise a number of concerns that must be adequately addressed before the paper can be accepted. Some of the required revisions will likely require further experimentation within the framework of the presented studies and techniques.

1\) Please clarify how the DEG mapping to anatomy was performed. It is unclear if the mapping relates to one of the DEGs or many. Analysis such as ISH patterns of top DEGs for each molecular subgroup could be overlapped to create a density map to provide a better sense of how the DEGs that strongly drove clustering map to location.

2\) Please provide information on the total number of starter cells that were labeled with the RABV within the VTA and DRN including images in the figures. If this represents a small proportion, it is possible that only a fraction of the total LHb neurons were retrogradely labeled. Please also provide data showing the specificity to dopamine or GABA starter neurons (i.e. expand Figure 5---figure supplement 2).

3\) Please clarify in the Results, Materials and methods, and figures the vector used for the retrograde labeling in the DRN. If G-containing RABV was used the virus could jump more than a synapse over time, rendering the interpretation difficult.

4\) The data in Figure 5 could be improved to demonstrate the differential targeting of VTA neuron subtypes and the DRN. It is difficult to visualize *Chrm3* and *RbV-N* colocalization. Enlarged images similar to Figure 4 are also needed to improve this visualization. Additionally, please add images for *Gpr151, Vgf*, and *Sst/Gpr151*.

5\) The experiments performed in the DRN lack the detailed analysis performed in the VTA. The DRN and MRN contain different neuronal populations, and the LHb seems to innervate serotonin containing neurons (Lecca et al., 2017). If the authors intend to keep the DRN data in this study, then please provide a more refined connectivity analysis similar to the VTA analysis. Please also provide discussion on the DRN data.

6\) An issue in the LHb field relates to the medial-lateral subdivisions and whether the structure is better thought of in terms of compartments or gradients. It seems the authors are in a good position to add to this debate with their data but elect to \"fit\" their data into existing structures while noting the gradients in the text. For example, *Chrm3* staining in Figure 4B seems to cover the entire ventral portion. Please include descriptions of gradient expression as well. Additional, ISHs of these targets themselves or somehow obtaining this data from the Allen Brain could address this issue.

7\) In the second paragraph of the subsection "Anatomical distribution of MHb neuronal subtypes", it is difficult to tell from mean z-scored data and the circle plots that genes such as *Lm03* and *Esam* are preferentially expressed in one subtype. Please address this.
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Author response

> Essential revisions:
>
> The reviewers raise a number of concerns that must be adequately addressed before the paper can be accepted. Some of the required revisions will likely require further experimentation within the framework of the presented studies and techniques.
>
> 1\) Please clarify how the DEG mapping to anatomy was performed. It is unclear if the mapping relates to one of the DEGs or many. Analysis such as ISH patterns of top DEGs for each molecular subgroup could be overlapped to create a density map to provide a better sense of how the DEGs that strongly drove clustering map to location.

In order to determine the spatial location of each genetically defined LHb subgroup we have now analyzed gene expression patterns using FISH for two DEGs for each subgroup (Figure 4, Figure 4---figure supplement 2 and Figure 4---figure supplement 3). Using FISH we show that expression of DEGs from the same subgroup overlap (Figure 4---figure supplement 3), while expression of DEGs from different subgroups is mutually exclusive (Figure 4). We also show that the spatial distribution along the medial/lateral axis of each of these DEGs is distinct between subgroups, but similar within a subgroup (Figure 4---figure supplement 2). Using the Allen Brain Atlas, (Lein et al., 2007) we have also examined the expression of many other LHb and MHb DEGs and find that they show similar expression patterns to the genes that for which we performed FISH analysis. Therefore, we are confident that the expression patterns of the DEGs we chose to highlight with FISH (i.e. *Sst, Chrm3, Gpr151, Vgf, Rbfox1, Pbx3,* and *Plch1*) are representative of the gene expression patterns of each LHb subgroup. The illustration in Figure 4---figure supplement 1 summarizes these observations. Please also see response to Essential revision 6 below.

> 2\) Please provide information on the total number of starter cells that were labeled with the RABV within the VTA and DRN including images in the figures. If this represents a small proportion, it is possible that only a fraction of the total LHb neurons were retrogradely labeled.

Approximately 12% (451/3754 cells/4 mice) of VGAT+ VTA neurons were starter cells in VGAT-IRES-Cre retrograde labeling experiments. In DAT-IRES-Cre experiments, approximately 18% (468/2598 cells/3 mice) of DAT+ VTA neurons were starter cells (Figure 5---figure supplement 2). Therefore, as in all studies using psuedotyped G-deleted rabies virus, a small subset of the total population of VTA neurons were putative starter cells. These data are now included in the legend for Figure 5---figure supplement 2.

Unlike the experiments in the VTA, the DRN experiments used a nonpsuedotyped G-deleted rabies virus (referred to in figures as RbV-GFP); therefore, in these experiments there were no starter cells (Figure 5---figure supplement 3). The nonpseudotyped G-deleted rabies virus is axon infecting, but does not spread across synapses due to deletion of the rabies glycoprotein (G). As the virus is nonpseudotyped, TVA is no longer needed for infection and the virus acts in a similar way to many other retrograde tracers such as cholera toxin or retrobeads, but we can amplify its signal by performing FISH for the viral gene *RbV-N*.

> Please also provide data showing the specificity to dopamine or GABA starter neurons (i.e. Expand Figure 5---figure supplement 2).

To examine the specificity of our starter cell population in the VGAT-IRES-Cre and DAT-IRES-Cre monosynaptic tracing experiments we injected AAV-DIO-TVA, but not AAV-DIO-RVG, followed by EnvA-RbV-GFP into the VTA. This allows initial infection of pseudotyped rabies virus into cells expressing the TVA receptor, but due to omission of RVG, does not allow subsequent spread of the virus. Therefore, all cells expressing *RbV-N,* but not *Cre* are due to non-specific expression of TVA. Our new data show that 99% of *RbV-N+* cellsin the VGAT-IRES-Cre and 95% *RbV-N+* cells in the DAT-IRES-Cre mice also express *Cre* indicating high specificity of our viruses for *Cre+* cells in VTA. Of course, these percentages are likely underestimates due to false negatives (i.e. inability to detect Cre by FISH in Cre-expressing neurons). These data are now included in Figure 5---figure supplement 2C.

> 3\) Please clarify in the Results, Materials and methods, and figures the vector used for the retrograde labeling in the DRN. If G-containing RABV was used the virus could jump more than a synapse over time, rendering the interpretation difficult.

As stated above (see Essential revision2), the DRN experiments used a nonpsuedotyped G-deleted rabies virus (Figure 5---figure supplement 3). The nonpseudotyped G-deleted rabies virus is axon infecting, but does not spread across synapses due to deletion of the rabies glycoprotein (G). As the virus is nonpseudotyped, TVA is no longer needed for infection and the virus acts in a similar way to many other retrograde tracers such as cholera toxin or retrobeads. We have clarified this detail in the Materials and methods, Results, and figure legends. Additionally, we have moved all of the DRN data to supplementary figures (Figure 5---figure supplement 3) to diminish confusion due to differences in methodology in the two types of experiments.

> 4\) The data in Figure 5 could be improved to demonstrate the differential targeting of VTA neuron subtypes and the DRN. It is difficult to visualize Chrm3 and RbV-N colocalization. Enlarged images similar to Figure 4 are also needed to improve this visualization. Additionally, please add images for Gpr151, Vgf, and Sst/Gpr151.

We added larger images to visualize *RbV-N* colocalization with DEGs in Figure 5 and Figure 5---figure supplement 3. We also included histograms depicting the medial/lateral distribution of *RbV-N*+ cells for each injection location/cell-type. Interestingly, these new analyses revealed different distributions of retrogradely labeled cells for each target region/cell-type.

> 5\) The experiments performed in the DRN lack the detailed analysis performed in the VTA. The DRN and MRN contain different neuronal populations, and the LHb seems to innervate serotonin containing neurons (Lecca et al., 2017). If the authors intend to keep the DRN data in this study, then please provide a more refined connectivity analysis similar to the VTA analysis. Please also provide discussion on the DRN data.

All of the DRN data has been moved to Figure 5---figure supplement 3. This experiment used a non-pseudotyped rabies (G-deleted) virus (referred to in the figures as RbV-GFP) which differs from the pseudotyped rabies (G-deleted) virus (referred to in figures as EnvA-RbV-GFP) used in the VGAT-IRES-Cre and DAT-IRES-Cre experiments (see Essential revisions 2 and 3). Therefore, due to differences in methodology, it is more appropriate to present these data in separate figures. We believe that this showing this data is worthwhile as it despite the fact that there is no genetically defined starter cell population. We also include discussion of this data and new analysis in the Results and Discussion section.

> 6\) An issue in the LHb field relates to the medial-lateral subdivisions and whether the structure is better thought of in terms of compartments or gradients. It seems the authors are in a good position to add to this debate with their data but elect to \"fit\" their data into existing structures while noting the gradients in the text. For example, Chrm3 staining in Figure 4B seems to cover the entire ventral portion. Please include descriptions of gradient expression as well. Additional, ISHs of these targets themselves or somehow obtaining this data from the Allen Brain could address this issue.

We replaced the image in Figure 4B with an image that is more representative of pattern of *Chrm3* we observe. Also, we now show the distribution of cells positive for DEGs *Chrm3, Gpr151,* and *Vgf* as well as expression levels in individual cells along the medial/lateral axis of LHb in Figure 4---figure supplement 2.

To show that these patterns of DEG expression are representative of each cluster rather than unique to those particular DEGs, we performed FISH with a new set of DEGs: *Rbfox1, Pbx3,* and *Plch1*, and analyzed gene expression and location. These new genes were chosen because, similar to *Chrm3, Gpr151,* and *Vgf,* they are DEGs that are enriched in a specific LHb cluster (Oval/medial, lateral, and marginal, respectively). In Figure 4---figure supplement 3, using FISH we show that *Rbfox1, Pbx3,* and *Plch1* are expressed by the same cells as *Chrm3, Gpr151,* and *Vgf,* respectively. In Figure 4---figure supplement 2, we show that the distribution of cells positive for *Rbfox1, Pbx3,* and *Plch1* along the medial/lateral axis also matches the distribution of *Chrm3, Gpr151,* and *Vgf*. We did not observe obvious gradients in expression along the medial/lateral axis for most of the genes; however, *Plch1* expression did gradually decrease in expression for cells positioned more lateral within the LHb. These new results and analysis are now described and discussed in the Results and Discussion sections.

> 7\) In the second paragraph of the subsection "Anatomical distribution of MHb neuronal subtypes", it is difficult to tell from mean z-scored data and the circle plots that genes such as Lm03 and Esam are preferentially expressed in one subtype. Please address this.

In Figure 2---figure supplement 3, we have added violin plots showing gene expression levels (log normalized and scaled) of DEGs for all MHb and LHb clusters shown in Figure 2 and 3. These plots show the distribution of expression levels for *Lmo3* and *Esam* for all clusters, illustrating their preferential expression in the ventral 2/3 of MHb, and the ventrolateral MHb clusters, respectively.
